Does contrast agent injection during trans-catheter aortic valve implantation negatively affect kidney function?

Journal Title: Kardiologia Polska - Year 2011, Vol 69, Issue 3

Abstract

Trans-catheter aortic valve implantation (TAVI) has recently emerged as an alternative to conventional surgery in high-risk surgical patients with haemodynamically significant aortic valve stenosis. However, patients referred for TAVI are usually elderly individuals (> 80 years) who frequently also suffer from renal impairment. Trans-catheter valve therapies require extensive use of contrast injections with a risk of nephrotoxicity.

Authors and Affiliations

Ewa Podolecka, Zbigniew Chmielak, Marcin Demkow, Piotr Michałek, Stefania Lidia Chojnowska, Tomasz Hryniewiecki, Krzysztof Kuśmierski, Katarzyna Czerwińska, Janina Stępińska, Witold Rużyłło, Adam Witkowski

Keywords

Download PDF file
  • EP ID EP85610
  • DOI -
  • Views 120
  • Downloads 0

How To Cite

Ewa Podolecka, Zbigniew Chmielak, Marcin Demkow, Piotr Michałek, Stefania Lidia Chojnowska, Tomasz Hryniewiecki, Krzysztof Kuśmierski, Katarzyna Czerwińska, Janina Stępińska, Witold Rużyłło, Adam Witkowski (2011). Does contrast agent injection during trans-catheter aortic valve implantation negatively affect kidney function?. Kardiologia Polska, 69(3), 251-255. https://europub.co.uk/articles/-A-85610